Sponsor:
trueNorth Medical Centres
Code:
NCT06349902
Conditions
Hepatitis C
Eligibility Criteria
Sex: All
Age: 0+
Healthy Volunteers: Not accepted
Interventions
Re-Link
Brief summary:
Conditions
Hepatitis C
Study ID
NCT06349902
Start date
Mar 12, 2024
Status verified date
Mar, 2024
Completion date
Dec 31, 2024
Anticipated
Primary completion date
Aug 31, 2024
Anticipated
Eligibility Criteria
Sex: All
Age: 0+
Healthy Volunteers: Not accepted
Enrollment
5000 participants
Anticipated
Arms
Positive HCV RNA, no sufficient previous course of DAA treatment.
Interventions
Re-Link
Primary outcome measure
Central contacts
Locations
trueNorth Medical Centre
Recruiting
Toronto, Ontario, Canada, M5B 2A5
Contacts
Principal Investigator:
Chris Cavacuiti, BA, MD, MHSc
Sponsor
trueNorth Medical Centres
Last update posted
Apr 5, 2024
Last verified
Mar, 2024
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by trueNorth Medical Centres on 2024-04-05.